Research Articles
Advanced Analytical Methods for Autologous Cell Product Characterization: Overcoming Scalability and Regulatory Hurdles in 2025
This article provides a comprehensive overview of the current landscape and emerging trends in analytical methods for characterizing autologous cell therapy products.
Navigating Autologous Therapy Comparability: A Strategic Guide for Process Changes in 2025
This article provides a comprehensive guide for researchers and drug development professionals on designing and implementing robust comparability studies for process changes in autologous cell and gene therapies.
Overcoming Limited Starting Material in Autologous Cell Therapy: Strategies for Scalability and Efficacy
This article addresses the critical challenge of limited and variable starting material in autologous cell therapy, a major bottleneck in manufacturing and clinical efficacy.
Industrializing the Living Drug: Scalability Strategies for Autologous Cell Therapies in 2025
This article provides a comprehensive analysis of the scalability challenges and strategic solutions for autologous cell therapy manufacturing.
Modular Manufacturing Platforms for Autologous Therapies: Scaling Personalized Medicine
This article explores the transformative role of modular manufacturing platforms in overcoming the scalability, cost, and consistency challenges of autologous cell therapies.
Optimizing Cell Therapy Recovery: A Comprehensive Comparison of Thawing Methods for Viability and Potency
For researchers and drug development professionals, the thawing process is a critical determinant of success in cell therapy applications.
Controlled Ice Nucleation: A Critical Parameter for Optimizing Cryopreservation Protocols and Post-Thaw Viability
This article provides a comprehensive analysis of ice nucleation temperature as a pivotal yet often overlooked factor in cryopreservation protocol optimization.
Optimized Cryopreservation with CryoStor® CS10: A Step-by-Step Protocol for Maximizing Cell Recovery and Function
This comprehensive guide provides researchers, scientists, and drug development professionals with a detailed, evidence-based protocol for cryopreserving sensitive cell types using CryoStor® CS10.
Strategies for Reducing DMSO Cytotoxicity in Cryopreserved Cell Therapies: From Foundational Science to Clinical Application
This article provides a comprehensive analysis of strategies to mitigate Dimethyl Sulfoxide (DMSO) cytotoxicity in cryopreserved cell therapies, a critical challenge in the biomanufacturing of advanced therapeutic products.
Validating cGMP Cryopreservation Protocols for Cell Therapies: A Guide to Quality, Compliance, and Patient Safety
This article provides a comprehensive framework for researchers and drug development professionals on validating cryopreservation protocols within cGMP cell therapy manufacturing.